This initiative unites MC10’s powerful technological capabilities in physiological sensing and pattern recognition algorithms with the University of Rochester’s clinical expertise and commitment to big data analytics to drive solutions for today’s most pressing healthcare challenges.

University of Rochester’s Hajim School of Engineering and Applied Sciences will lead the effort. Robert Clark, Dean of the School of the Hajim School of Engineering and Applied Sciences, sees the collaboration with MC10 as supportive of the university’s efforts to translate patient healthcare data into actionable findings.

"At University of Rochester, we are committed to fostering collaborative research to improve human health," Dean Clark said. "We see great potential in working with MC10 and in exploiting the biometric insights that are realized from MC10’s technology platform in addressing some of the greatest challenges we see in healthcare today."

MC10 sought out a collaboration with the University of Rochester based on its world-class facilities and its vision to be the 21st century leader in data science. The university’s efforts in this field include a commitment of $100 million to the creation of the Georgen Institute for Data Science, a center focused on using healthcare data and leading edge data analytics to advance medicine.

MC10 is uniquely positioned to support the university in its research efforts with its BioStamp platform which consists of MC10’s novel biometric sensing devices, a companion software application, and an end-to-end cloud storage and computing platform.

BioStamp will be put to the test in a variety of clinical settings by a diverse group of researchers at the University of Rochester, which will further drive MC10’s collection of big data and development of disease-specific algorithms for use in predictive health analytics.

MC10 will maximize its engineering support for this collaboration by opening an office in Rochester, NY and it also intends to collaborate with graduate students from the Hajim School of Engineering and Applied Sciences.

Additionally, University of Rochester Medical Center’s Dr. Ray Dorsey, Professor of Neurology and Director of CHET, will lead research efforts in the field of neurodegenerative disease.

"Connected health technologies hold the potential to disrupt the way we monitor the progression of neurodegenerative disorders today and to assess the response to novel therapeutics," said Dr. Dorsey.